NCT04026425

Brief Summary

This study aims to collect and identify key outcome measures or disease parameters in ME/CFS that are altered during elevated symptoms relative to baseline by gathering information before and after symptom provocation using a two-day cardiopulmonary exercise test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 2, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 19, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

July 7, 2023

Status Verified

July 1, 2023

Enrollment Period

3.6 years

First QC Date

July 2, 2019

Last Update Submit

July 5, 2023

Conditions

Keywords

cardiopulmonary exercise test (CPET)post-exertional malaise (PEM)

Outcome Measures

Primary Outcomes (9)

  • Volume of oxygen consumed at peak effort

    Volume of oxygen consumed at peak effort during CPET 1 and during CPET 2.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Volume of oxygen consumed at ventilatory/anaerobic threshold (VAT)

    VAT is a non-invasive surrogate measure for anaerobic threshold, which is indicated during incremental exercise by a non-linear increase in rate of carbon dioxide production relative to rate of oxygen consumption.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Rate of work performed at peak effort

    Rate of work performed at peak effort during CPET 1 and during CPET 2. Rate of work is measured in Watts.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Rate of work performed at VAT

    Rate of work performed at VAT during CPET 1 and during CPET 2. Rate of work is measured in Watts.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Heart rate at peak effort

    Heart rate at peak effort during CPET 1 and during CPET 2.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Heart rate at VAT

    Heart rate at VAT during CPET 1 and during CPET 2.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Systolic blood pressure at seated rest

    Systolic blood pressure at seated rest 1-minute before the start of CPET 1 and 1-minute before the start of CPET 2.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Systolic blood pressure at peak effort

    Systolic blood pressure at peak effort during CPET 1 and during CPET 2.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

  • Respiratory Exchange Ratio (RER) at peak effort

    RER at peak effort during CPET 1 and during CPET 2. RER is calculated as the rate of carbon dioxide production divided by the rate of oxygen consumption, and during exercise is an indicator of participant effort.

    During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date.

Study Arms (2)

ME/CFS

EXPERIMENTAL

Adults with ME/CFS

Other: Two-day cardiopulmonary exercise test

Healthy controls

ACTIVE COMPARATOR

Healthy, low-active adults

Other: Two-day cardiopulmonary exercise test

Interventions

A series of two cardiopulmonary exercise tests (CPETs) performed over two days. Participants will perform a CPET and then will return approximately 24 hours later to perform the second CPET. The CPET begins with 3 minutes of seated rest followed by cycling during incremental workloads which increases 15 watts throughout each minute of exercise. The participant will cycle until volitional exhaustion and/or the participant and/or test administrator determines to stop the test. Actual exercise time usually varies between 8-10 minutes.

Healthy controlsME/CFS

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with ME/CFS
  • Adults 18 to 70 years of age

You may not qualify if:

  • Recent history of panic attacks within the past 6 months
  • Diagnosis of schizophrenia, major depressive disorder, bipolar disorder, or an anxiety disorder such as OCD or PTSD
  • Hospitalized for a psychological condition within the last 6 months
  • Unwilling to stop taking nutritional supplements, including probiotics, two weeks before the exercise tests.
  • Unwilling to stop pain medication and stimulant medication two days before the exercise tests.
  • Smoker, or stopped smoking less than 1 year ago
  • Pregnant or breastfeeding
  • Diabetic
  • Have an orthopedic limitation that prohibits cycle exercise
  • Excessive alcohol consumption
  • Healthy Volunteers:
  • Healthy
  • Low-active
  • Adults 18 to 70 years of age
  • Recent history of panic attacks within the past 6 months
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

ID Med

Torrance, California, 90505, United States

Location

Ithaca College

Ithaca, New York, 14850, United States

Location

Weill Cornell Medicine

New York, New York, 10021, United States

Location

Related Publications (1)

  • Keller B, Receno CN, Franconi CJ, Harenberg S, Stevens J, Mao X, Stevens SR, Moore G, Levine S, Chia J, Shungu D, Hanson MR. Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations. J Transl Med. 2024 Jul 5;22(1):627. doi: 10.1186/s12967-024-05410-5.

Related Links

MeSH Terms

Conditions

Fatigue Syndrome, Chronic

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesEncephalomyelitisNeuroinflammatory DiseasesNervous System DiseasesNeuromuscular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Betsy Keller, Ph.D.

    Ithaca College

    STUDY DIRECTOR
  • Geoff Moore, M.D.

    Ithaca College

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2019

First Posted

July 19, 2019

Study Start

August 1, 2018

Primary Completion

March 15, 2022

Study Completion

March 31, 2023

Last Updated

July 7, 2023

Record last verified: 2023-07

Locations